Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies Inc.
Agilent Technologies, BioTrove to Streamline Drug Discovery Using High-Throughput Mass Spectrometry
November 14th, 2008
Agilent Technologies Inc. (NYSE:A) and BioTrove announced that they have signed a non-exclusive value-added reseller agreement to enable BioTrove to provide an end-to-end solution for mass spectrometry-based drug discovery. This solution will combine technology leader BioTrove's RapidFire Mass Spectrometry sample preparation system with Agilent's rugged, accurate mass spectrometers. The reseller agreement expands on an established strategic relationship between Agilent and BioTrove, furthering both companies' ability to enhance customer workflows. BioTrove will provide an integrated solution for drug discovery using mass spectrometry analysis, affording customers access...
Source: Health Business Week (2008-11-14)
|
